| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.3M | +38.0% |
| Cost of Revenue | $1.6M | -18.8% |
| R&D Expense | $36.9M | +15.8% |
| SG&A Expense | $15.9M | +10.1% |
| Operating Income | -$35.1M | -2.4% |
| Interest Expense | $2.4M | +11.7% |
| Net Income | -$35.3M | +2.6% |
| EPS (Basic) | -$1.55 | -868.8% |
| EPS (Diluted) | -$1.55 | -868.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.5M | -12.8% |
| Accounts Receivable | $3.4M | -47.2% |
| Inventory | $2.1M | +13.0% |
| Current Assets | $51.4M | -37.1% |
| Total Assets | $60.1M | -34.7% |
| Current Liabilities | $34.0M | +238.1% |
| Long-term Debt | $21.2M | +2.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.3M | +29.6% |
| Capital Expenditures | $111K | -42.8% |
| Investing Cash Flow | $19.8M | +29.6% |
| Financing Cash Flow | $83K | -99.8% |
| Free Cash Flow | -$26.4M | +29.6% |
| Stockholders' Equity |
| $25.0M |
| -56.8% |